SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-011729
Filing Date
2022-05-02
Accepted
2022-05-02 09:11:25
Documents
74
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form-20f.htm   iXBRL 20-F 2859877
2 form-20f_001.jpg GRAPHIC 23198
3 form-20f_002.jpg GRAPHIC 44727
4 form-20f_003.jpg GRAPHIC 45601
5 form-20f_004.jpg GRAPHIC 40778
6 form-20f_005.jpg GRAPHIC 50951
7 ex1-1.htm EX-1.1 329863
8 ex4-7.htm EX-4.7 17828
9 ex12-1.htm EX-12.1 12150
10 ex12-2.htm EX-12.2 12053
11 ex13-1.htm EX-13.1 10491
12 ex15-1.htm EX-15.1 4923
  Complete submission text file 0001493152-22-011729.txt   8646459

Data Files

Seq Description Document Type Size
13 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT glmd-20211231.xsd EX-101.SCH 34537
14 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT glmd-20211231_cal.xml EX-101.CAL 48934
15 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT glmd-20211231_def.xml EX-101.DEF 154490
16 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT glmd-20211231_lab.xml EX-101.LAB 303308
17 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT glmd-20211231_pre.xml EX-101.PRE 234478
68 EXTRACTED XBRL INSTANCE DOCUMENT form-20f_htm.xml XML 1131149
Mailing Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317
Business Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317 97236938448
Galmed Pharmaceuticals Ltd. (Filer) CIK: 0001595353 (see all company filings)

IRS No.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36345 | Film No.: 22879627
SIC: 2834 Pharmaceutical Preparations